Role of oxidative stress and molecular changes in liver fibrosis: a review - PubMed (original) (raw)
Review
Role of oxidative stress and molecular changes in liver fibrosis: a review
V Sánchez-Valle et al. Curr Med Chem. 2012.
Abstract
Liver fibrosis represents a health problem with significant morbidity and mortality that affects 100 million people worldwide. It is a final pathway to several chronic liver diseases and is characterized by excess collagen and accumulation of extracellular matrix in response to chronic hepatocellular damage. Clinical and experimental data suggest that oxidative stress (OS) mediates the progression of fibrosis, and that OS-related molecules may act as mediators of molecular and cellular events implicated in liver fibrosis. The generation of reactive oxygen species (ROS) plays an important role in producing liver damage and initiating hepatic fibrogenesis. OS disrupts lipids, proteins and DNA, induces necrosis and apoptosis of hepatocytes and amplifies the inflammatory response. ROS also stimulate the production of profibrogenic mediators from Kupffer cells and circulating inflammatory cells and directly activate hepatic stellate cells, resulting in the initiation of fibrosis. Advances in understanding the mechanisms involved in fibrosis have identified new molecular targets with therapeutic potential for more targeted and personalized control of this disease. This review will highlight recent concepts in OS, antioxidants and the molecular pathways involved in hepatic fibrosis.
Similar articles
- Targeting Oxidative Stress for the Treatment of Liver Fibrosis.
Luangmonkong T, Suriguga S, Mutsaers HAM, Groothuis GMM, Olinga P, Boersema M. Luangmonkong T, et al. Rev Physiol Biochem Pharmacol. 2018;175:71-102. doi: 10.1007/112_2018_10. Rev Physiol Biochem Pharmacol. 2018. PMID: 29728869 Review. - Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E, Fabregat I. Crosas-Molist E, et al. Redox Biol. 2015 Dec;6:106-111. doi: 10.1016/j.redox.2015.07.005. Epub 2015 Jul 14. Redox Biol. 2015. PMID: 26204504 Free PMC article. Review. - Oxidative and nitrosative stress and fibrogenic response.
Urtasun R, Conde de la Rosa L, Nieto N. Urtasun R, et al. Clin Liver Dis. 2008 Nov;12(4):769-90, viii. doi: 10.1016/j.cld.2008.07.005. Clin Liver Dis. 2008. PMID: 18984466 Free PMC article. Review. - Fighting Liver Fibrosis with Naturally Occurring Antioxidants.
Lin L, Zhou F, Shen S, Zhang T. Lin L, et al. Planta Med. 2018 Dec;84(18):1318-1333. doi: 10.1055/a-0757-0008. Epub 2018 Oct 12. Planta Med. 2018. PMID: 30312974 Review. - Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells.
Shu Y, Liu X, Huang H, Wen Q, Shu J. Shu Y, et al. Mol Biol Rep. 2021 Feb;48(2):1915-1924. doi: 10.1007/s11033-021-06171-w. Epub 2021 Feb 20. Mol Biol Rep. 2021. PMID: 33609264 Free PMC article. Review.
Cited by
- Therapeutic Effects of Eugenol in Polycystic Ovarian Rats Induced by Estradiol Valerate: A Histopathological and A Biochemical Study.
Kokabiyan Z, Yaghmaei P, Jameie SB, Hajebrahimi Z. Kokabiyan Z, et al. Int J Fertil Steril. 2022 Aug 21;16(3):184-191. doi: 10.22074/ijfs.2021.537724.1176. Int J Fertil Steril. 2022. PMID: 36029055 Free PMC article. - Saccharomyces boulardii modulates oxidative stress and renin angiotensin system attenuating diabetes-induced liver injury in mice.
Barssotti L, Abreu ICME, Brandão ABP, Albuquerque RCMF, Ferreira FG, Salgado MAC, Dias DDS, De Angelis K, Yokota R, Casarini DE, Souza LB, Taddei CR, Cunha TS. Barssotti L, et al. Sci Rep. 2021 Apr 28;11(1):9189. doi: 10.1038/s41598-021-88497-w. Sci Rep. 2021. PMID: 33911129 Free PMC article. - Glutamate-Cysteine Ligase Catalytic Subunit Attenuated Hepatitis C Virus-Related Liver Fibrosis and Suppressed Endoplasmic Reticulum Stress.
Fu N, Li D, Li W, Zhao W, Zhang S, Liu L, Zhao S, Du J, Kong L, Wang R, Zhang Y, Nan Y. Fu N, et al. Front Mol Biosci. 2020 Aug 18;7:199. doi: 10.3389/fmolb.2020.00199. eCollection 2020. Front Mol Biosci. 2020. PMID: 33015132 Free PMC article. - Alisma Shugan Decoction (ASD) Ameliorates Hepatotoxicity and Associated Liver Dysfunction by Inhibiting Oxidative Stress and p65/Nrf2/JunD Signaling Dysregulation In Vivo.
Sun Y, Pan H, Shen S, Xia Z, Yu Z, Li C, Sun P, Xin C. Sun Y, et al. Med Sci Monit. 2020 Jul 16;26:e921738. doi: 10.12659/MSM.921738. Med Sci Monit. 2020. PMID: 32672153 Free PMC article. - Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM, Liang S, Zhou B. Bai YM, et al. Aging (Albany NY). 2024 Feb 15;16(4):3773-3789. doi: 10.18632/aging.205559. Epub 2024 Feb 15. Aging (Albany NY). 2024. PMID: 38364259 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical